Toth Financial Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40
Closed -$19.7K 1005
2026
Q1
$19.7K Buy
40
+39
+3,900% +$21.2K ﹤0.01% 489
2025
Q4
$580 Buy
+1
New +$566 ﹤0.01% 805
2024
Q3
Sell
-5
Closed -$2.77K 774
2024
Q2
$2.77K Buy
+5
New +$2.86K ﹤0.01% 578
2023
Q3
Sell
-10
Closed -$5.22K 848
2023
Q2
$5.22K Sell
10
-2
-17% -$1.08K ﹤0.01% 549
2023
Q1
$6.92K Buy
+12
New +$6.76K ﹤0.01% 503
2022
Q4
Sell
-74
Closed -$38K 804
2022
Q3
$38K Buy
74
+73
+7,300% +$40.9K 0.01% 301
2022
Q2
$1K Buy
+1
New +$550 ﹤0.01% 673
2018
Q1
Sell
-108
Closed -$21K 459
2017
Q4
$21K Buy
+108
New +$20.7K 0.01% 273

Other funds holding TMO

Toth Financial Advisory's TMO Position: Q2 2026 in Review

Toth Financial Advisory sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 40 shares — an estimated $19.7K sold.

Toth Financial Advisory first reported a position in TMO in Q4 2017 and held it in 8 quarters. The position peaked at $38K in Q3 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Toth Financial Advisory reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Toth Financial Advisory sold 40 Thermo Fisher Scientific shares in Q2 2026, an estimated $19.7K.
  • Toth Financial Advisory first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 8 quarters.
  • Toth Financial Advisory's Thermo Fisher Scientific position peaked at $38K in Q3 2022.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.